Epidemiological studies of atomic bomb radiation at the Radiation Effects Research Foundation

References

• Abrahamson S. 2009. Radiation Effects Research Foundation Research Program: Historical Perspectives, 1946-1995. RERF Commentary and Review Series 2-96. Hiroshima, Japan: RERF; [accessed 2018 Nov 20] https://www.rerf.or.jp/en/library/list-e/scientific_pub/crlist-en/1996-en/cr9602-en/
   Google Scholar
• Arakawa E. 1959. Radiation dosimetry in Hiroshima and Nagasaki atomic bomb survivors. ABCC Technical Report 14-59. Hiroshima, Japan: ABCC; [accessed 2018 Nov 20] https://www.rerf.or.jp/library/scidata/tr_all/TR1959-14.pdf
   Google Scholar
• Beebe GW, Ishida M, Jablon S. 1962. Studies of the mortality of A-bomb survivors. I. Plan of study and mortality in the medical subsample (selection 1), 1950-1958. Radiat Res. 16:253–280. [Corresponding to LSS Report 1 of ABCC TR 5-61]
   PubMed Web of Science ®Google Scholar
• Beebe GW, Kato H, Land CE. 1971. Studies of the mortality of A-bomb survivors. 4. Mortality and radiation dose, 1950–1966. Radiat Res. 48:613–649. [Corresponding to LSS Report 5 of ABCC TR 11–70]
   PubMed Web of Science ®Google Scholar
• Beebe GW, Kato H, Land CE. 1978. Studies of the mortality of A-bomb survivors: 6. mortality and radiation dose, 1950–1974. Radiat Res. 75:138–201. [Corresponding to LSS Report 8 of RERF TR 1-77]
   PubMed Web of Science ®Google Scholar
• Cahoon EK, Preston DL, Pierce DA, Grant E, Brenner AV, Mabuchi K, Utada M, Ozasa K. 2017. Lung, laryngeal and other respiratory cancer incidence among Japanese atomic bomb survivors: an updated analysis from 1958 through 2009. Radiat Res. 187:538–548.
   PubMed Web of Science ®Google Scholar
• Choshi K, Takaku I, Mishima H, Takase T, Neriishi S, Finch SC, Otake M. 1983. Ophthalmologic changes related to radiation exposure and age in adult health study sample, Hiroshima and Nagasaki. Radiat Res. 96:560–579.
   PubMed Web of Science ®Google Scholar
• Cogan DG, Martin SF, Kimura SJ. 1949. Atom bomb cataracts. Science. 110:654–655.
   PubMed Web of Science ®Google Scholar
• Cologne JB, Preston DL. 2000. Longevity of atomic-bomb survivors. Lancet. 356:303–307.
   PubMed Web of Science ®Google Scholar
• Cullings HM, Fujita S, Funamoto S, Grant EJ, Kerr GD, Preston DL. 2006. Dose estimation for atomic bomb survivor studies: its evolution and present status. Radiat Res. 166:219–254.
   PubMed Web of Science ®Google Scholar
• Cullings HM, Grant EJ, Egbert SD, Watanabe T, Oda T, Nakamura F, Yamashita T, Fuchi H, Funamoto S, Marumo K, et al. 2017. DS02R1: Improvements to atomic bomb survivors' input data and implementation of Dosimetry System 2002 (DS02) and resulting changes in estimated doses. Health Phys. 11:56–97.
   Web of Science ®Google Scholar
• Delongchamp RR, Mabuchi K, Yoshimoto Y, Preston DL. 1997. Cancer mortality among atomic bomb survivors exposed in utero or as young children, October 1950-May 1992. Radiat Res. 147:385–395.
   PubMed Web of Science ®Google Scholar
• Folley JH, Borges W, Yamawaki T. 1952. Incidence of leukemia in survivors of the atomic bomb in Hiroshima and Nagasaki, Japan. Am J Med. 13:311–321.
   PubMed Web of Science ®Google Scholar
• Francis T, Jablon S, Moore FE. 1959. Report of ad hoc committee for appraisal of ABCC program. ABCC Technical Report 33-59. Hiroshima, Japan: Atomic Bomb Casualty Commission (ABCC); [accessed 2018 Nov 20] https://www.rerf.or.jp/library/scidata/tr_all/TR1959-33.pdf
   Google Scholar
• Fujiwara S, Kusumi S, Cologne J, Akahoshi M, Kodama K, Yoshizawa H. 2000. Prevalence of anti-hepatitis C virus antibody and chronic liver disease among atomic bomb survivors. Radiat Res 154:12–19.
   PubMed Web of Science ®Google Scholar
• Fujiwara S, Sharp GB, Cologne JB, Kusumi S, Akahoshi M, Kodama K, Suzuki G, Yoshizawa H. 2003. Prevalence of hepatitis B virus infection among atomic bomb survivors. Radiat Res. 159:780–786.
   PubMed Web of Science ®Google Scholar
• Fujiwara S, Suyama A, Cologne JB, Akahoshi M, Yamada M, Suzuki G, Koyama K, Takahashi N, Kasagi E, Grant EJ, et al. 2008. Prevalence of adult-onset multifactorial disease among offspring of atomic bomb survivors. Radiat Res. 170:451–457.
   PubMed Web of Science ®Google Scholar
• Grant EJ, Brenner A, Sugiyama H, Sakata R, Sadakane A, Utada M, Cahoon EK, Milder CM, Soda M, Cullings HM, et al. 2017. Solid cancer incidence among the life span study of atomic bomb survivors: 1958-2009. Radiat Res. 187:513–537.
   PubMed Web of Science ®Google Scholar
• Grant EJ, Cologne JB, Sharp GB, Eguchi H, Stevens RG, Izumi S, Kim YM, Berrington de González A, Ohishi W, Nakachi K. 2018. Bioavailable serum estradiol may alter radiation risk of postmenopausal breast cancer: a nested case-control study. Int J Radiat Biol. 94:97–105.
   PubMed Web of Science ®Google Scholar
• Grant EJ, Furukawa K, Sakata R, Sugiyama H, Sadakane A, Takahashi I, Utada M, Shimizu Y, Ozasa K. 2015. Risk of death among the children of the atomic bomb survivors, an update after 62 years of follow-up: a cohort study. Lancet Oncol. 16:1316–1323.
   PubMed Web of Science ®Google Scholar
• Hiroshima City Office. 2018. Genbaku-hibakusha-taisakujigyo-gaiyo (Summary of Relief Measures for Atomic Bomb Survivors), Hiroshima: Hiroshima City Office. (in Japanese)
   Google Scholar
• Hsu W-L, Preston DL, Soda M, Sugiyama H, Funamoto S, Kodama K, Kimura A, Kamada N, Dohy H, Tomonaga M, et al. 2013. The incidence of leukemia, lymphoma and multiple myeloma among atomic bomb survivors: 1950–2001. Radiat Res. 179:361–382.
   PubMed Web of Science ®Google Scholar
• Imaizumi M, Ashizawa K, Neriishi K, Akahoshi M, Nakashima E, Usa T, Tominaga T, Hida A, Sera N, Soda M, et al. 2008. Thyroid diseases in atomic bomb survivors exposed in utero. J Clin Endocrinol Metab. 93:1641–1648.
   PubMed Web of Science ®Google Scholar
• Imaizumi M, Ohishi W, Nakashima E, Sera N, Neriishi K, Yamada M, Tatsukawa Y, Takahashi I, Fujiwara S, Sugino K, et al. 2015. Association of radiation dose with prevalence of thyroid nodules among atomic bomb survivors expose in childhood (2007-2011). JAMA Intern Med. 175:228–236.
   PubMed Web of Science ®Google Scholar
• Imaizumi M, Ohishi W, Nakashima E, Sera N, Neriishi K, Yamada M, Tatsukawa Y, Takahashi I, Fujiwara S, Sugino K, et al. 2017. Thyroid Dysfunction and Autoimmune Thyroid Diseases Among Atomic Bomb Survivors Exposed in Childhood. J Clin Endocrinol Metab. 102:2516–2524.
   PubMed Web of Science ®Google Scholar
• Imaizumi M, Usa T, Tominaga T, Neriishi K, Akahoshi M, Nakashima E, Ashizawa K, Hida A, Soda M, Fujiwara S, et al. 2006. Radiation dose-response relationships for thyroid nodules and autoimmune thyroid diaseses in Hiroshima and Nagasaki atomic bomb survivors 55-58 years after radiation exposure. Jama. 295:1011–1022.
   PubMed Web of Science ®Google Scholar
• Ishida M, Beebe GW. 1959. Research Plan for Joint NIH-ABCC Study of Life Span of A-Bomb Survivors. ABCC Technical Report 04-59. Hiroshima, Japan: ABCC; [accessed 2018 Nov 20] https://www.rerf.or.jp/en/library/list-e/scientific_pub/trtoc-en/tr1959-en/tr5904-en/ (abstract only)
   Google Scholar
• Ishida M, Jablon S. 1964. JNIH-ABCC Life Span Study. Hiroshima-Nagasaki. Report 4. Mortality in A-bomb survivors by age cohorts 1950-59. ABCC Technical Report 14-64. Hiroshima, Japan: ABCC; [accessed 2018 Nov 20] https://www.rerf.or.jp/library/scidata/tr_all/TR1964-14.pdf
   Google Scholar
• Ishimaru T, Hoshino T, Ichimaru M, Okada H, Tomiyasu T, Tsuchimoto T, Yamamoto T. 1969. Leukemia in atomic bomb survivors Hiroshima and Nagasaki. ABCC Technical Report 25-69. Hiroshima, Japan: ABCC; [accessed 2018 Nov 20] https://www.rerf.or.jp/library/scidata/tr_all/TR1969-25.pdf
   Google Scholar
• Itakura K, Takahashi I, Nakashima E, Yanagi M, Kawasaki R, Neriishi K, Wang JJ, Wong TY, Hida A, Ohishi W, et al. 2015. Exposure to atomic bomb radiation and age-related macular degeneration in later life: the Hiroshima-Nagasaki atomic bomb survivor study. Invest Ophthalmol Vis Sci. 56:5401–5406.
   PubMed Web of Science ®Google Scholar
• Izumi S, Koyama K, Soda M, Suyama A. 2003. Cancer incidence in children and young adults did not increase relative to parental exposure to atomic bombs. Br J Cancer. 89:1709–1713.
   PubMed Web of Science ®Google Scholar
• Izumi S, Suyama A, Koyama K. 2003. Radiation-related mortality among offspring of atomic bomb survivors: a half-century of follow-up. Int J Cancer. 107:292–297.
   PubMed Web of Science ®Google Scholar
• Jablon S, Ishida M, Beebe GW. 1964. Studies of the mortality of A-bomb survivors. 2. Mortality in selections I and II, 1950-1959. Radiat Res. 21:423–445. [Corresponding to LSS Report 2 of ABCC TR 1-63]
   PubMed Web of Science ®Google Scholar
• Jablon S, Ishida M, Yamasaki M. 1965. Studies of the mortality of A-bomb survivors. 3. Description of the sample and mortality, 1950-1960. Radiat Res. 25:25–52. [Corresponding to LSS Report 3. of ABCC TR 15-63]
   PubMed Web of Science ®Google Scholar
• Jablon S, Kato H. 1972. Studies of the mortality of A-bomb survivors. 5. Radiation dose and mortality, 1950-1970. Radiat Res. 50:649–698. [Corresponding to LSS Report 6 of ABCC TR 10-71]
   PubMed Web of Science ®Google Scholar
• Kato H, Brown CC, Hoel DG, Schull WJ. 1982. Studies of the mortality of A-bomb survivors. Report 7. Mortality, 1950-1978: Part II. Mortality from causes other than cancer and mortality in early entrants. Radiat Res. 91:243–264. [Corresponding to LSS Report 9, Part 2, of RERF TR 5-81]
   PubMed Web of Science ®Google Scholar
• Kato H, Mayumi M, Nishioka K, Hamilton HB. 1983. The relationship of hepatitis B surface antigen and antibody to atomic bomb radiation in the Adult Health Study sample, 1975-1977. Am J Epidemiol. 117:610–620.
   PubMed Web of Science ®Google Scholar
• Kato H, Schull WJ. 1982. Studies of the mortality of A-bomb survivors. 7. Mortality, 1950-1978: Part I. Cancer mortality. Radiat Res. 90:395–432. [Corresponding to LSS Report 9, Part 1, of RERF TR 12-80]
   PubMed Web of Science ®Google Scholar
• Kato H, Schull WJ, Neel JV. 1966. A cohort-type study of survival in the children of parents exposed to atomic bombings. Am J Hum Genet. 18:339–373.
   PubMed Web of Science ®Google Scholar
• Kiuchi Y, Yokoyama T, Takamatsu M, Tsuiki E, Uematsu M, Kinoshita H, Kumagami T, Kitaoka T, Minamoto A, Neriishi K, et al. 2013. Glaucoma in atomic bomb survivors. Radiat Res. 180:422–430.
   PubMed Web of Science ®Google Scholar
• Mabuchi K, Soda M, Ron E, Tokunaga M, Ochikubo S, Sugimoto S, Ikeda T, Terasaki M, Preston DL, Thompson DE. 1994. Cancer incidence in atomic bomb survivors. Part I: Use of the tumor registries in Hiroshima and Nagasaki for incidence studies. Radiat Res. 137:S1–S16.
   PubMed Web of Science ®Google Scholar
• Miller RJ, Fujino T, Nefzger MD. 1967. Lens findings in Atomic bomb survivors. A review of major ophthalmic surveys at the atomic Bomb Casualty Commission (1949-1962). Arch Ophthalmol. 78:697–704.
   PubMedGoogle Scholar
• Milton RC, Shohoji T. 1968. Tentative 1965 radiation dose estimation for atomic bomb survivors, Hiroshima and Nagasaki. ABCC Technical Report 1-68. Hiroshima, Japan: ABCC; [accessed 2018 Nov 20] https://www.rerf.or.jp/library/scidata/tr_all/TR1968-01.pdf
   Google Scholar
• Minamoto A, Taniguchi H, Yoshitani N, Mukai S, Yokoyama T, Kumagami T, Tsuda Y, Mishima HK, Amemiya T, Nakashima E, et al. 2004. Cataract in atomic bomb survivors. Int J Radiat Biol. 80:339–345.
   PubMed Web of Science ®Google Scholar
• Moriyama IM, Kato H. 1973. JNIH-ABCC Life Span Study Report 7. Mortality experience of A-bomb survivors, 1950-72. ABCC Technical Report 15-73. Hiroshima, Japan: ABCC; [accessed 2018 Nov 20] https://www.rerf.or.jp/library/scidata/tr_all/TR1973-15.pdf
   Google Scholar
• Muller HJ. 1927. Artificial transmutation of the gene. Science. 66:84–87.
   PubMedGoogle Scholar
• Nagasaki City Office 2018. Genbaku-hibakusha-taisakujigyo-gaiyo (Summary of Relief Measures for Atomic Bomb Survivors), 2018. Nagasaki: Nagasaki City Office; (in Japanese)
   Google Scholar
• Nakamura N. 2019. History of radiation genetics: light and darkness. (submitted to Int J Radiat Biol)
   PubMed Web of Science ®Google Scholar
• Nakashima E, Akahoshi M, Neriishi K, Fujiwara S. 2007. Systolic blood pressure and systolic hypertension in adolescence of atomic bomb survivors exposed in utero. Radiat Res. 168:593–599.
   PubMed Web of Science ®Google Scholar
• Nakashima E, Neriishi K, Minamoto A. 2006. A reanalysis of atomic-bomb cataract data, 2000-2002: a threshold analysis. Health Phys. 90:154–160.
   PubMed Web of Science ®Google Scholar
• Neel JV, Kato H, Schull WJ. 1974. Mortality in the children of atomic bomb survivors and controls. Genetics 76:311–336.
   PubMed Web of Science ®Google Scholar
• Neel JV, Schull WJ. 1956. The effect of exposure to the atomic bombs on pregnancy termination in Hiroshima and Nagasaki. Washington DC: National Academy of Sciences, National Research Council;
   Google Scholar
• Neel JV, Schull WJ. 1991. The Children of Atomic Bomb Survivors: A Genetic Study. Washington DC: National Academy Press
   Google Scholar
• Neriishi K, Akiba S, Amano T, Ogino T, Kodama K. 1995. Prevalence of hepatitis B surface antigen, hepatitis B e antigen and antibody, and antigen subtypes in atomic bomb survivors. Radiat Res. 144:215–221.
   PubMed Web of Science ®Google Scholar
• Ohishi W, Fujiwara S, Cologne JB, Suzuki G, Akahoshi M, Nishi N, Tsuge M, Chayama K. 2011. Impact of radiation and hepatitis virus infection on risk of hepatocellular carcinoma. Hepatology. 53:1237–1245.
   PubMed Web of Science ®Google Scholar
• Otake M, Schull WJ. 1998. Radiation-related brain damage and growth retardation among the prenatally exposed atomic bomb survivors. Int J Radiat Biol. 74:159–171.
   PubMed Web of Science ®Google Scholar
• Oughterson AW, Warren S. editors. 1956. Medical effects of the atomic bomb in Japan. New York: McGraw-Hill;
   Google Scholar
• Ozasa K, Grant EJ, Cullings HM, Shore RE. 2013. Invited commentary: Missing doses in the Life Span Study of Japanese atomic bomb survivors. Am J Epidemiol. 177:569–573.
   PubMed Web of Science ®Google Scholar
• Ozasa K, Shimizu Y, Suyama A, Kasagi F, Soda M, Grant EJ, Sakata R, Sugiyama H, Kodama K. 2012. Studies of the mortality of atomic bomb survivors, Report 14, 1950-2003: an overview of cancer and noncancer diseases. Radiat Res. 177:229–243.
   PubMed Web of Science ®Google Scholar
• Ozasa K, Takahashi I, Grant EJ. 2016. Radiation-related risks of non-cancer outcomes in the atomic bomb survivors. Ann Icrp. 45:253–261.
   PubMedGoogle Scholar
• Ozasa K, Takahashi I, Grant EJ, Kodama K. 2017. Cardiovascular disease among atomic bomb survivors. Int J Radiat Biol. 93:1145–1150.
   PubMed Web of Science ®Google Scholar
• Pham TM, Sakata R, Grant EJ, Shimizu Y, Furukawa K, Takahashi I, Sugiyama H, Kasagi F, Soda M, Suyama A, et al. 2013. Radiation exposure and the risk of mortality from noncancer respiratory diseases in the Life Span Study, 1950-2005. Radiat Res. 180:539–545.
   PubMed Web of Science ®Google Scholar
• Pierce DA, Shimizu Y, Preston DL, Vaeth M, Mabuchi K. 1996. Studies of the mortality of atomic bomb survivors. Report 12, Part I. Cancer: 1950-1990. Radiat Res. 146:1–27.
   PubMed Web of Science ®Google Scholar
• Pierce DA, Stram DO, Vaeth M. 1990. Allowing for random errors in radiation dose estimates for the atomic bomb survivor data. Radiat Res. 123:275–284. Sep
   PubMed Web of Science ®Google Scholar
• Preston DL, Cullings H, Suyama A, Funamoto S, Nishi N, Soda M, Mabuchi K, Kodama K, Kasagi F, Shore RE. 2008. Solid cancer incidence in atomic bomb survivors exposed in utero or as young children. J Natl Cancer Inst. 100:428–436.
   PubMedGoogle Scholar
• Preston DL, Kato H, Kopecky KJ, Fujita S. 1987. Studies of the mortality of A-bomb survivors. 8. Cancer mortality, 1950-1982. Radiat Res. 111:151–178. [Corresponding to LSS Report 10 of RERF TR 1-86]
   PubMed Web of Science ®Google Scholar
• Preston DL, Kusumi S, Tomonaga M, Izumi S, Ron E, Kuramoto A, Kamada N, Dohy H, Matsuo T, Matsuo T. 1994. Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950-1987. Radiat Res. 137:S68–S97.
   PubMed Web of Science ®Google Scholar
• Preston DL, Ron E, Tokuoka S, Funamoto S, Nishi N, Soda M, Mabuchi K, Kodama K. 2007. Solid cancer incidence in atomic bomb survivors: 1958-1998. Radiat Res. 168:1–64.
   PubMed Web of Science ®Google Scholar
• Preston DL, Shimizu Y, Pierce DA, Suyama A, Mabuchi K. 2003. Studies of mortality of atomic bomb survivors. Report 13: Solid cancer and noncancer disease mortality: 1950-1997. Radiat Res. 160:381–407.
   PubMed Web of Science ®Google Scholar
• Radiation Effects Research Foundation (RERF) 2014. A Brief Description. Hiroshima, Japan: RERF; [accessed 2017 Nov 20] https://www.rerf.or.jp/uploads/2017/09/briefdescript_e.pdf
   Google Scholar
• Radiation Effects Research Foundation (RERF) 1975. Articles of Incorporation. [accessed 2017 Nov 20] https://www.rerf.or.jp/uploads/2017/09/aie.pdf
   Google Scholar
• Radiation Effects Research Foundation (RERF) 1987. US-Japan Joint Reassessment of Atomic Bomb Radiation Dosimetry in Hiroshima and Nagasaki (DS86). Hiroshima, Japan: RERF; [accessed 2017 Nov 20] https://www.rerf.or.jp/en/library/list-e/scids/ds86-en/
   Google Scholar
• Richardson DB, Sugiyama H, Nishi N, Sakata R, Shimizu Y, Grant EJ, Soda M, Hsu WL, Suyama A, Kodama K, et al. 2009. Ionizing radiation and leukemia mortality among Japanese atomic bomb survivors, 1950-2000. Radiat Res. 172:368–382.
   PubMed Web of Science ®Google Scholar
• Richardson DB, Sugiyama H, Wing S, Sakata R, Grant EJ, Shimizu Y, Nishi N, Geyer S, Soda M, Suyama A, et al. 2009. Positive associations between ionizing radiation and lymphoma mortality among men. Am J Epidemiol. 169:969–976.
   PubMed Web of Science ®Google Scholar
• Russell WL. 1951. X-ray-induced mutations in mice. Cold Spring Harb Symp Quant Biol. 16:327–336.
   PubMedGoogle Scholar
• Sasaki H, Wong FL, Yamada M, Kodama K. 2002. The effects of aging and radiation exposure on blood pressure levels of atomic bomb survivors. J Clin Epidemiol. 55:974–981.
   PubMed Web of Science ®Google Scholar
• Schull WJ, Otake M, Neel JV. 1981. Genetic effects of the atomic bombs: a reappraisal. Science. 213:1220–1227.
   PubMed Web of Science ®Google Scholar
• Shimizu Y, Kato H, Schull WJ. 1990. Studies of the mortality of A-bomb survivors. 9. Mortality, 1950-1985: Part 2. Cancer mortality based on the recently revised doses (DS86). Radiat Res. 121:120–141. [Corresponding to LSS Report 11, Part 2, of RERF TR 5-88]
   PubMed Web of Science ®Google Scholar
• Shimizu Y, Kato H, Schull WJ, Hoel DG. 1992. Studies of the mortality of A-bomb survivors. 9. Mortality, 1950-1985: Part 3. Noncancer mortality based on the revised doses (DS86). Radiat Res. 130:249–266. [Corresponding to LSS Report 11, Part 3, of RERF TR 2-91]
   PubMed Web of Science ®Google Scholar
• Shimizu Y, Kato H, Schull WJ, Preston DL, Fujita S, Pierce DA. 1989. Studies of the mortality of A-bomb survivors. 9. Mortality, 1950-1985: Part 1. Comparison of risk coefficients for site-specific cancer mortality based on the DS86 and T65DR shielded kerma and organ doses. Radiat Res. 118:502–524. [Corresponding to LSS Report 11, Part 1, of RERF TR 12-87]
   PubMed Web of Science ®Google Scholar
• Shimizu Y, Kodama K, Nishi N, Kasagi F, Suyama A, Soda M, Grant E, Sugiyama H, Sakata R, Moriwaki H, et al. 2010. Radiation exposure and circulatory disease risk: Hiroshima and Nagasaki atomic bomb survivor data, 1950-2003. BMJ. 340:b5349.
   PubMed Web of Science ®Google Scholar
• Shimizu Y, Pierce DA, Preston DL, Mabuchi K. 1999. Studies of the mortality of atomic bomb survivors. Report 12, Part II. Noncancer mortality: 1950-1990. Radiat Res. 152:374–389.
   PubMed Web of Science ®Google Scholar
• Sposto R, Preston DL. 1992. Correcting for catchment area nonresidency in studies based on tumor-registry data. ABCC Commentary and Review Series 1-92. Hiroshima, Japan: ABCC; [accessed 2017 Nov 20] https://www.rerf.or.jp/library/list/scientific_pub/crlist/1992-2/cr9201/
   Google Scholar
• Suzuki G, Cullings H, Fujiwara S, Hattori N, Matsuura S, Hakoda M, Akahoshi M, Kodama K, Tahara E. 2007. Low-positive antibody titer against Helicobacter pylori cytotoxin-associated gene A (CagA) may predict future gastric cancer better than simple seropositivity against H. pylori CagA or against H. pylori. Cancer Epidemiol Biomarkers Prev. 16:1224–1228.
   PubMed Web of Science ®Google Scholar
• Takahashi I, Abbott RD, Ohshita T, Takahashi T, Ozasa K, Akahoshi M, Fujiwara S, Kodama K, Matsumoto M. 2012. A prospective follow-up study of the association of radiation exposure with fatal and non-fatal stroke among atomic bomb survivors in Hiroshima and Nagasaki (1980-2003). BMJ Open. 2:e000654.
   PubMed Web of Science ®Google Scholar
• Takahashi I, Shimizu Y, Grant EJ, Cologne J, Ozasa K, Kodama K. 2017. Heart disease mortality in the life span study, 1950-2008. Radiat Res. 187:319–332.
   PubMed Web of Science ®Google Scholar
• Tatsukawa Y, Cologne JB, Hsu WL, Yamada M, Ohishi W, Hida A, Furukawa K, Takahashi N, Nakamura N, Suyama A, et al. 2013. Radiation risk of individual multifactorial diseases in offspring of the atomic-bomb survivors: a clinical health study. J Radiol Prot. 33:281–293.
   PubMed Web of Science ®Google Scholar
• Tatsukawa Y, Misumi M, Yamada M, Masunari N, Oyama H, Nakanishi S, Fukunaga M, Fujiwara S. 2013. Alterations of body mass index and body composition in atomic bomb survivors. Int J Obes (Lond). 37:1123–1128.
   PubMed Web of Science ®Google Scholar
• Tatsukawa Y, Nakashima E, Yamada M, Funamoto S, Hida A, Akahoshi M, Sakata R, Ross NP, Kasagi F, Fujiwara S, et al. 2008. Cardiovascular disease risk among atomic bomb survivors exposed in utero, 1978-2003. Radiat Res. 170:269–274.
   PubMed Web of Science ®Google Scholar
• Thompson DE, Mabuchi K, Ron E, Soda M, Tokunaga M, Ochikubo S, Sugimoto S, Ikeda T, Terasaki M, Izumi S, et al. 1994. Cancer incidence in atomic bomb survivors. Part II: solid tumors, 1958-1987. Radiat Res. 137:S17–S67.
   PubMed Web of Science ®Google Scholar
• Wakabayashi T, Kato H, Ikeda T, Schull WJ. 1983. Studies of the mortality of A-bomb survivors, Report 7. Part III. Incidence of cancer in 1959-78, based on the Tumor Registry, Nagasaki. Radiat Res. 93:112–146. [Corresponding to LSS Report 9, Part 3, of RERF TR 6-81]
   PubMed Web of Science ®Google Scholar
• Wong FL, Yamada M, Sasaki H, Kodama K, Akiba S, Shimaoka K, Hosoda Y. 1993. Noncancer disease incidence in the atomic bomb survivors: 1958-1986. Radiat Res. 135:418–430.
   PubMed Web of Science ®Google Scholar
• Wong FL, Yamada M, Sasaki H, Kodama K, Hosoda Y. 1999. Effects of radiation on the longitudinal trends of total serum cholesterol levels in the atomic bomb survivors. Radiat Res. 151:736–746.
   PubMed Web of Science ®Google Scholar
• Yamada M, Izumi S. 2002. Psychiatric sequelae in atomic bomb survivors in Hiroshima and Nagasaki two decades after the explosions. Soc Psychiatry Psychiatr Epidemiol. 37:409–415.
   PubMed Web of Science ®Google Scholar
• Yamada M, Landes RD, Mimori Y, Nagano Y, Sasaki H. 2016. Radiation effects on cognitive function among atomic bomb survivors exposed at or after adolescence. Am J Med. 129:586–591.
   PubMed Web of Science ®Google Scholar
• Yamada M, Sasaki H, Kasagi F, Akahoshi M, Mimori Y, Kodama K, Fujiwara S. 2002. Study of cognitive function among the Adult Health Study (AHS) population in Hiroshima and Nagasaki. Radiat Res. 158:236–240.
   PubMed Web of Science ®Google Scholar
• Yamada M, Wong FL, Fujiwara S, Akahoshi M, Suzuki G. 2004. Noncancer disease incidence in atomic bomb survivors, 1958-1998. Radiat Res. 161:622–662.
   PubMed Web of Science ®Google Scholar
• Yoshimoto Y, Kato H, Schull WJ. 1988. Risk of cancer among children exposed in utero to A-bomb radiations, 1950-84. Lancet. 2:665–669.
   PubMed Web of Science ®Google Scholar
• Young WY, Kerr GD. 2005. Reassessment of the Atomic Bomb Radiation Dosimetry for Hiroshima and Nagasaki -Dosimetry System 2002 (DS02). Hiroshima, Japan: RERF; [accessed 2017 Nov 20] https://www.rerf.or.jp/en/library/list-e/scids/ds02-en/
   Google Scholar